This article was automatically translated from the original Turkish version.
Pigmentation disorders are conditions resulting from abnormalities in the production or distribution of melanin in the skin. Melanin is the pigment responsible for skin color and is produced by cells called melanocytes. Pigmentation disorders can manifest as hyperpigmentation (excessive pigment production) or hypopigmentation (pigment deficiency). These disorders may be congenital or develop later in life and can arise from various factors. Although pigmentation disorders are often regarded as cosmetic concerns, in some cases they may indicate an underlying serious disease.
Hyperpigmentation refers to dark spots or areas on the skin caused by an accumulation of melanin beyond normal levels. These lesions can be triggered by various factors including sun exposure, hormonal changes, medications, or skin injuries.
Melasma is a hyperpigmentation disorder characterized by brown or gray-brown patches, typically appearing on the face. It is commonly associated with pregnancy (known as the mask of pregnancy) or hormonal changes such as those caused by oral contraceptives. UV light can worsen melasma. Melasma usually occurs on sun-exposed areas such as the forehead, cheeks, nose, and upper lip.
Postinflammatory hyperpigmentation refers to dark spots that develop after inflammation or injury to the skin. Conditions such as eczema, psoriasis, or skin trauma can lead to this type of hyperpigmentation. Although the discoloration often fades over time, it may sometimes be permanent.
Lentigo is a hyperpigmentation disorder appearing as small, dark brown spots on the skin. Lentigines typically develop due to sun exposure and are also known as age spots. Different types exist, including lentigo simplex and solar lentigo.
Hypopigmentation refers to light-colored patches or areas on the skin resulting from reduced or lost melanin production. This condition can be congenital or acquired.
Vitiligo is a hypopigmentation disorder characterized by white patches on the skin due to loss of melanocytes. These patches typically appear symmetrically on both sides of the body. Vitiligo is considered an autoimmune condition in which the immune system attacks melanocytes. It can occur at any age and, although generally regarded as a cosmetic issue, it may cause psychological effects in some individuals.
Albinism is a congenital hypopigmentation disorder characterized by a complete absence of melanin production. This condition is marked by lack of pigment in the skin, hair, and eyes. Albinism can also lead to additional problems such as visual impairments and extreme sensitivity to sunlight.
Pityriasis alba is a mild hypopigmentation disorder commonly seen in children. It is characterized by mild scaling and light-colored patches on the skin. Pityriasis alba typically appears on the face, arms, and trunk and often resolves spontaneously over time.
Pigmentation disorders can result from a combination of genetic, environmental, and hormonal factors. Sunlight is one of the most common triggers of pigmentation disorders. UV radiation can stimulate melanin production, leading to hyperpigmentation. Hormonal changes, particularly during pregnancy or with the use of oral contraceptives, can trigger hyperpigmentation disorders such as melasma. Additionally, skin injuries, inflammation, and certain medications can also contribute to pigmentation disorders.
The diagnosis of pigmentation disorders is typically made through clinical examination. Dermatologists may make a diagnosis based on the appearance, distribution of lesions, and the patient’s medical history. In some cases, a biopsy or other laboratory tests may be required. For disorders with autoimmune origins such as vitiligo, additional tests may be performed to investigate underlying causes.
The treatment of pigmentation disorders varies depending on the type and severity of the condition. The primary goal of treatment is to restore normal pigmentation and improve cosmetic appearance.
In the treatment of hyperpigmentation, topical agents such as hydroquinone, retinoids, kojic acid, and azelaic acid are used. These medications help lighten spots by reducing melanin production. For hypopigmentation, topical corticosteroids and calcineurin inhibitors may be used.
Laser therapy and chemical peels are effective methods for treating hyperpigmentation lesions. Laser therapy targets melanin pigment to lighten the discoloration. Chemical peels work by removing the outer layer of skin to promote a new, more even skin tone.
Sunscreen plays a crucial role in both the treatment and prevention of pigmentation disorders. Sunlight can worsen hyperpigmentation and cause new lesions to form. Therefore, regular use of broad-spectrum sunscreen is recommended.
Bolognia, Jean L., and John M. Pawelek. "Biology of Hypopigmentation." Journal of the American Academy of Dermatology 19, no. 2 (1988): 217–255.
Callender, Valerie D., St. Surin-Lord, Susan, Elise C. Davis, and Maritza Maclin. "Postinflammatory Hyperpigmentation: Etiologic and Therapeutic Considerations." American Journal of Clinical Dermatology 12, no. 2 (2011): 87–99.
Grimes, Pearl E. "Melasma: Etiologic and Therapeutic Considerations." Archives of Dermatology 133, no. 11 (2007): 1453–1457.
Ortonne, Jean-Paul. "Pigmentary Disorders of the Skin." In Clinical Dermatology, 4th ed. Oxford: Blackwell Publishing, 2006.
Taïeb, Alain, and Mauro Picardo. "Vitiligo." New England Journal of Medicine 360, no. 2 (2009): 160–169.
No Discussion Added Yet
Start discussion for "Pigmentation Disorders" article
Hyperpigmentation Disorders
Melasma
Postinflammatory Hyperpigmentation
Lentigo
Hypopigmentation Disorders
Vitiligo
Albinism
Pityriasis Alba
Causes of Pigmentation Disorders
Diagnosis of Pigmentation Disorders
Treatment of Pigmentation Disorders
Topical Treatments
Laser Therapy and Chemical Peels
Sunscreen